Product Information
BICALUTAMIDE 50 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.4300 per EA under NDC 62559089030. Its NADAC has been published 224 times since May 12, 2021.
FDA first approved this application on Oct 4, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Bicalutamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559089030
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
BICALUTAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA020498FDA Approved
10/4/1995
TE Code
AB
On Market Since
10/26/2020
Pharmacological Classes
Price Statistics
The NADAC for BICALUTAMIDE 50 MG TABLET has been published 224 times since May 12, 2021, and over the history we have for it it has risen 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4300 per EA |
|---|---|
| All-time high | $0.4654 (Jun 12, 2024) |
| All-time low | $0.2572 (Apr 19, 2023) |
| Median price | $0.3339 |
| Average price | $0.3410 |
| Largest weekly change | +50.2% (Jul 17, 2024) |
| Weeks tracked | 224 |
| Tracking since | May 12, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+32.3%
5Y
+23.1%
All
+18.9%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BICALUTAMIDE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BICALUTAMIDE 50 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.4300 per EA (NDC 62559089030), effective Aug 20, 2025.
How has the price of BICALUTAMIDE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for BICALUTAMIDE 50 MG TABLET has risen 18.9%. It has been tracked across 224 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for BICALUTAMIDE 50 MG TABLET?
Since May 12, 2021, the NADAC for BICALUTAMIDE 50 MG TABLET has ranged from a low of $0.2572 (Apr 19, 2023) to a high of $0.4654 (Jun 12, 2024), with a median of $0.3339 per EA.
Are there cheaper alternatives to BICALUTAMIDE 50 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BICALUTAMIDE 50 MG TABLET, is $0.4028 per EA — about 6% below BICALUTAMIDE 50 MG TABLET.
Who manufactures BICALUTAMIDE 50 MG TABLET?
BICALUTAMIDE 50 MG TABLET (NDC 62559089030) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.